Table 1.
Baseline characteristics of patients with large artery occlusive disease (n=353)
| Aspirin (n=173) | LMWH (n=180) | ||
|---|---|---|---|
| Age (years) | |||
| Mean (SD) | 67·2 (10·5) | 66·7 (9·8) | |
| Median (range) | 68 (35–89) | 69 (37–88) | |
| Sex | |||
| Male | 100 (58%) | 106 (59%) | |
| Female | 73 (42%) | 74 (41%) | |
| Time to treatment (h) | |||
| Mean (SD) | 28 (12) | 30 (11) | |
| 0–24 h | 73 (42%) | 66 (37%) | |
| >24–48 h | 100 (58%) | 114 (63%) | |
| NIHSS at baseline | |||
| Mean (SD) | 7 (4) | 7 (4) | |
| Median (range) | 6 (1–21) | 6 (1–22) | |
| Score 0–8 | 123 (71%) | 129 (72%) | |
| Score ≥9 | 50 (29%) | 51 (28%) | |
| Prestroke modified Rankin scale | |||
| Score 0 | 145 (84%) | 150 (83%) | |
| Score 1 | 28 (16%) | 30 (17%) | |
| Known risk factor | |||
| History of stroke/transient ischaemic attack | 33 (19%) | 39 (22%) | |
| Ischaemic heart disease | 15 (9%) | 20 (11%) | |
| Hypertension | 136 (79%) | 141 (78%) | |
| Diabetes mellitus | 87 (50%) | 73 (41%) | |
| Insulin dependent | 2 | 1 | |
| Non-insulin dependent | 85 | 72 | |
| Hyperlipidaemia | 82 (47%) | 86 (48%) | |
| Smoking history (including current and ex-smoker) | 76 (44%) | 82 (46%) | |
| Self-reported habitual drinking | 29 (17%) | 25 (14%) | |
| Peripheral vascular disease | 7 (4%) | 3 (2%) | |
Data are numbers (%), unless otherwise indicated. LMWH=Low-molecular-weight heparin; NIHSS=National Institutes of Health stroke scale.